Global Pharmaceutical Packaging Market - Forecasts from 2020 to 2025

February 2020 | 119 pages | ID: GF3A9CF3969EN
Knowledge Sourcing Intelligence LLP

Abstracts

The global pharmaceutical packaging market is projected to grow at a CAGR of 5.29% to reach US$110.654 billion by 2025, from US$81.198 billion in 2019. The pharmaceutical packaging is essential for containment and protection of the product, presentation, and information about the dosage form, identification of the components of the product and for the convenience associated with the administration of the product. The growth of the pharmaceutical packaging market is driven by the increasing demand for drug delivery devices, technological advancements, and reduction in the packaging cost with the advancement in the technology. A rise in the demand for reusable and specialty packaging is also expected to bolster the market growth during the given time frame. Additionally, with the growing e-commerce and online purchasing trend worldwide, drugs also need robust packaging keeping in view the safety of the product. Hence, the growing e-commerce industry is also driving the growth of the global pharmaceutical packaging market in the forecast period and in the upcoming years. On the basis of geography, North America is expected to hold a major share owing to the early adoption of technology, and the highest health expenditure of the United States among all the developed regions of the world. While the Asia Pacific region is expected to be the fastest-growing, this is due to the growing pharmaceutical industry, especially in the emerging economies of India and China. Also, with the prevalence of chronic diseases in the APAC region, the market for pharmaceutical packaging is projected to thrive due to the increasing demand for drugs supported by effective treatment procedures. Furthermore, growing health awareness among individuals worldwide is expected to provide an opportunity for the market to grow at a sustainable pace in the upcoming years.

The growing geriatric population is driving the growth of the global pharmaceutical packaging market in the forecast period.

The older population is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050 (source: National Institutes of Health). With the growing advancements in the healthcare sector, the elderly population is being highly benefitted in order to stay healthy. This is due to the innovations in drug technology leading to the development of targeted therapies. Additionally, with the growing trend of healthy aging, individuals above the age of 65 years are keen to keep a check on their day-to-day activities, hence, they are consuming required medicines in order to maintain good health.

Therefore, the growing geriatric population worldwide is providing an opportunity for the market to thrive at a rapid pace in the forecast period.

North America is expected to hold a significant market share in the forecast period.

The global pharmaceutical packaging market is estimated to hold the largest market share owing to the highest health spending of the United States, healthcare services are very expensive, most of the people in the country have medical insurance, and the country does not have a universal healthcare system. Additionally, there is a rising trend in the United States where individuals are moving from a volume-based to value-based care. A shift in the healthcare market dynamics is being observed which is further leading to better patient outcomes at lower costs. Changing demographics like an aging population, and a high prevalence of people with chronic diseases is further driving the growth of the pharmaceutical packaging market in the forecast period. With the high prevalence of diseases, patients look forward to effective treatments and this has led to advancements in technology and services providing the consumers to be in greater control of their own health management. Designing effective healthcare strategies according to the highly aware and curious citizens in addition to the unique healthcare system among the other developed regions has created a need for the provision of better health services emanating the growth of the global pharmaceutical packaging market in this region during the forecast period.

Segmentation:

• By Raw Materials
• Plastics and Polymers
• Glass
• Paper and Paperboard
• Metal Foils
• Others
• By Pharmaceutical Dosage Type
• Liquid Dosage
• Solid Dosage
• Semi Solid and Pressurized Products
• By Packaging Type
• Blister Packs
• Pre-Fillable Syringes
• Medical Specialty Bags
• Vials and Ampoules
• Pouches and Strip Bags
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• UK
• Germany
• France
• Others
• Middle East and Africa
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Others

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Market Segmentation

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
  4.3.1. Bargaining Power of Suppliers
  4.3.2. Bargaining Power of Buyers
  4.3.3. Threat of New Entrants
  4.3.4. Threat of Substitutes
  4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. GLOBAL PHARMACEUTICAL PACKAGING MARKET ANALYSIS, BY RAW MATERIALS

5.1. Introduction
5.2. Plastics and Polymers
5.3. Glass
5.4. Paper and Paperboard
5.5. Metal Foils
5.6. Others

6. GLOBAL PHARMACEUTICAL PACKAGING MARKET ANALYSIS, BY PHARMACEUTICAL DOSAGE TYPE

6.1. Introduction
6.2. Liquid Dosage
6.3. Solid Dosage
6.4. Semi Solid and Pressurized Products
6.5. Others

7. GLOBAL PHARMACEUTICAL PACKAGING MARKET ANALYSIS, BY PACKAGING TYPE

7.1. Introduction
7.2. Blister Packs
7.3. Pre-Fillable Syringes
7.4. Medical Specialty Bags
7.5. Vials and Ampoules
7.6. Pouches and Strip Bags
7.7. Others

8. GLOBAL PHARMACEUTICAL PACKAGING MARKET ANALYSIS, BY GEOGRAPHY

8.1. Introduction
8.2. North America
  8.2.1. North America Pharmaceutical Packaging Market, By Raw Materials, 2019 to 2025
  8.2.2. North America Pharmaceutical Packaging Market, By Pharmaceutical Dosage Type, 2019 to 2025
  8.2.3. North America Pharmaceutical Packaging Market, By Packaging Type, 2019 to 2025
  8.2.4. By Country
    8.2.4.1. United States
    8.2.4.2. Canada
    8.2.4.3. Mexico
8.3. South America
  8.3.1. South America Pharmaceutical Packaging Market, By Raw Materials, 2019 to 2025
  8.3.2. South America Pharmaceutical Packaging Market, By Pharmaceutical Dosage Type, 2019 to 2025
  8.3.3. South America Pharmaceutical Packaging Market, By Packaging Type, 2019 to 2025
  8.3.4. By Country
    8.3.4.1. Brazil
    8.3.4.2. Argentina
    8.3.4.3. Others
8.4. Europe
  8.4.1. Europe Pharmaceutical Packaging Market, By Raw Materials, 2019 to 2025
  8.4.2. Europe Pharmaceutical Packaging Market, By Pharmaceutical Dosage Type, 2019 to 2025
  8.4.3. Europe Pharmaceutical Packaging Market, By Packaging Type, 2019 to 2025
  8.4.4. By Country
    8.4.4.1. UK
    8.4.4.2. Germany
    8.4.4.3. France
    8.4.4.4. Others
8.5. Middle East and Africa
  8.5.1. Middle East and Africa Pharmaceutical Packaging Market, By Raw Materials, 2019 to 2025
  8.5.2. Middle East and Africa Pharmaceutical Packaging Market, By Pharmaceutical Dosage Type, 2019 to 2025
  8.5.3. Middle East and Africa Pharmaceutical Packaging Market, By Packaging Type, 2019 to 2025
  8.5.4. By Country
    8.5.4.1. United Arab Emirates
    8.5.4.2. Israel
    8.5.4.3. Others
8.6. Asia Pacific
  8.6.1. Asia Pacific Pharmaceutical Packaging Market, By Raw Materials, 2019 to 2025
  8.6.2. Asia Pacific Pharmaceutical Packaging Market, By Pharmaceutical Dosage Type, 2019 to 2025
  8.6.3. Asia Pacific Pharmaceutical Packaging Market, By Packaging Type, 2019 to 2025
  8.6.4. By Country
    8.6.4.1. Japan
    8.6.4.2. China
    8.6.4.3. India
    8.6.4.4. South Korea
    8.6.4.5. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. Amcor plc
10.2. CCL Industries
10.3. Gerresheimer AG
10.4. West Pharmaceutical Services, Inc.
10.5. IntraPac International LLC
10.6. Kl?ckner Pentaplast
10.7. SCHOTT AG
10.8. Aphena Pharma Solutions
10.9. Sonoco Products Company